US Patent Issued to Fred Hutchinson Cancer Center on April 14 for "Single-domain antibodies that bind ROR1" (Washington Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,801, issued on April 14, was assigned to Fred Hutchinson Cancer Center (Seattle).

"Single-domain antibodies that bind ROR1" was invented by Jason Price (Seattle), Colin E. Correnti (Seattle) and James M. Olson (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Single-domain antibodies that bind receptor tyrosine kinase (ROR1) are described. The single-domain antibodies can be used for multiple purposes including in research, imaging, diagnosis, and treatment of ROR1-related conditions. The disclosed single-domain antibodies can be used as anti-cancer therapeutics such as antibody-drug conjugates, multi-domain binding molecules, or recombinant ...